FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Sodium Chloride 14.6% Injection
Status: Currently in Shortage
»Date first posted: 04/05/2022
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition

Expand all

Fresenius Kabi USA, LLC (New 04/05/2022)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50 mEq per 20 mL (2.5 mEq per mL), Single dose plastic flip top vial, (NDC 63323-090-20) Backordered. Next release June 2022. Increase in Demand
100 mEq per 40 mL (2.5 mEq per mL), Single dose plastic flip top vial, (NDC 63323-090-40) Backordered. Next release June 2022. Increase in Demand

Hospira, Inc. (Reverified 05/10/2022)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
14.6% 100 mEq/40 mL (2.5 mEq/mL); Single Dose Plastic Fliptop Vial (NDC 00409-6660-75) Currently unavailable. Next Delivery and Estimated Recovery: October 2022 Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English